Association between different regional lymph node metastases of papillary thyroid carcinoma in adolescents and young adults

Wang,Lili; Zheng,Yahua; Ye,Yingpeng; Jiang,Zhekang; Lu,Jinling; Chen,Gaoxiang

doi:10.3892/ol.2024.14337

Association between different regional lymph node metastases of papillary thyroid carcinoma in adolescents and young adults

Authors:
- Lili Wang
- Yahua Zheng
- Yingpeng Ye
- Zhekang Jiang
- Jinling Lu
- Gaoxiang Chen
View Affiliations

Affiliations: Department of Nursing, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang 315040, P.R. China, Department of Hepatopancreatobiliary Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang 315040, P.R. China, Department of Thyroid and Breast Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang 315040, P.R. China
Published online on: March 11, 2024 https://doi.org/10.3892/ol.2024.14337
Article Number: 204
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Adolescents and young adults (AYA) describe the demographic aged between 15‑39 years diagnosed with cancer. This group is particularly at risk of papillary thyroid carcinoma (PTC) with a greater severity compared with other ages. Through comparative design, the present study aimed to quantify central lymph node metastasis (CLNM) risk in AYAs. A total of 463 AYA patients with PTC and 489 patients >39 years old with PTC from Ningbo Medical Center Lihuili Hospital (Ningbo, China) were enrolled. Details such as demographic data, serum indices and fine‑needle aspiration from the Electronic Medical Records System were extracted and analyzed. AYA patients had significantly higher rates of ipsilateral Hashimoto thyroiditis, thyroid capsular invasion (TCI), CLNM, larger tumors and more positive central lymph nodes (CLN). Independent risk factors of CLNM in AYA patients were as follows: Male sex, presence of TCI, multifocality, bilateral disease and maximum tumor diameter (MTD) ≥1.0 cm. Independent risk factors of lateral lymph node metastasis in AYAs with CLNM were as follows: MTD ≥1.0 cm, maximum diameter of positive CLN ≥1.0 cm, and presence of ipsilateral nodular goiter. Furthermore, AYA patients with PTC displayed significantly greater aggression in primary tumor invasion and neck lymph node metastasis. Based on these findings, a treatment stratification chart was created to guide the PTC treatment approach for AYAs. The present study is registered at the Chinese Clinical Trials Registry (trial registration no. ChiCTR2200064921) in November 2022.

View Figures

View References

1	Adolescent and Young Adult Oncology Progress Review Group, . Closing the gap: Research and care imperatives for adolescents and young adults with cancer. National Institutes of Health; Bethesda, MD: 2006
2	Janssen SHM, van der Graaf WTA, van der Meer DJ, Manten-Horst E and Husson O: Adolescent and Young Adult (AYA) Cancer Survivorship Practices: An Overview. Cancers (Basel). 13:48472021. View Article : Google Scholar : PubMed/NCBI
3	Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C and Anderson B: The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 4:288–298. 2008. View Article : Google Scholar : PubMed/NCBI
4	Tricoli JV, Boardman LA, Patidar R, Sindiri S, Jang JS, Walsh WD, McGregor PM III, Camalier CE, Mehaffey MG, Furman WL, et al: A mutational comparison of adult and adolescent and young adult (AYA) colon cancer. Cancer. 124:1070–1082. 2018. View Article : Google Scholar : PubMed/NCBI
5	Tricoli JV, Blair DG, Anders CK, Bleyer WA, Boardman LA, Khan J, Kummar S, Hayes-Lattin B, Hunger SP, Merchant M, et al: Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma. Cancer. 122:1017–1028. 2016. View Article : Google Scholar : PubMed/NCBI
6	Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C and Vaccarella S: The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. The Lancet Diabetes and Endocrinology. 4:264–272. 2022. View Article : Google Scholar : PubMed/NCBI
7	Rosenbaum MA and McHenry CR: Contemporary management of papillary carcinoma of the thyroid gland. Expert review of anticancer therapy. 9:317–329. 2014. View Article : Google Scholar : PubMed/NCBI
8	Miller KD, Fidler-Benaoudia M, Keegan TH, Hipp HS, Jemal A and Siegel RL: Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 70:443–459. 2020. View Article : Google Scholar : PubMed/NCBI
9	Yang Z, Heng Y, Lin J, Lu C, Yu D, Tao L and Cai W: Nomogram for predicting central lymph node metastasis in papillary thyroid cancer: A retrospective cohort study of two clinical centers. Cancer Res Treat. 52:1010–1018. 2020.PubMed/NCBI
10	Hod N, Hagag P, Baumer M, Sandbank J and Horne T: Differentiated thyroid carcinoma in children and young adults: Evaluation of response to treatment. Clin Nucl Med. 30:387–390. 2005. View Article : Google Scholar : PubMed/NCBI
11	Vriens MR, Moses W, Weng J, Peng M, Griffin A, Bleyer A, Pollock BH, Indelicato DJ, Hwang J and Kebebew E: Clinical and molecular features of papillary thyroid cancer in adolescents and young adults. Cancer. 117:259–267. 2011. View Article : Google Scholar : PubMed/NCBI
12	Dedhia PH, Saucke MC, Long KL, Doherty GM and Pitt SC: Physician perspectives of overdiagnosis and overtreatment of low-risk papillary thyroid cancer in the US. JAMA Netw Open. 5:e2287222022. View Article : Google Scholar : PubMed/NCBI
13	Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and Winchester DP: The eighth edition AJCC cancer staging manual: Continuing to build a bridge from a population-based to a more ‘personalized’ approach to cancer staging. CA Cancer J Clin. 67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
14	Miccoli P, Minuto MN, Ugolini C, Panicucci E, Massi M, Berti P and Basolo F: Papillary thyroid cancer: Pathological parameters as prognostic factors in different classes of age. Otolaryngology-Head and Neck Surgery. 138:200–203. 2008. View Article : Google Scholar : PubMed/NCBI
15	Lim H, Devesa SS, Sosa JA, Check D and Kitahara CM: Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA. 317:1338–1348. 2017. View Article : Google Scholar : PubMed/NCBI
16	Mulla M and Schulte KM: Central cervical lymph node metastases in papillary thyroid cancer: A systematic review of imaging-guided and prophylactic removal of the central compartment. Clin Endocrinol (Oxf). 76:131–136. 2012. View Article : Google Scholar : PubMed/NCBI
17	Feng JW, Yang XH, Wu BQ, Sun DL, Jiang Y and Qu Z: Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma. Clin Transl Oncol. 21:1482–1491. 2019. View Article : Google Scholar : PubMed/NCBI
18	Wang Y, Nie F, Wang G, Liu T, Dong T and Sun Y: Value of combining clinical factors, conventional ultrasound, and contrast-enhanced ultrasound features in preoperative prediction of central lymph node metastases of different sized papillary thyroid carcinomas. Cancer Manag Res. 13:3403–3415. 2021. View Article : Google Scholar : PubMed/NCBI
19	Heng Y, Yang Z, Zhou L, Lin J, Cai W and Tao L: Risk stratification for lateral involvement in papillary thyroid carcinoma patients with central lymph node metastasis. Endocrine. 68:320–328. 2020. View Article : Google Scholar : PubMed/NCBI
20	Zhao W, Chen S, Hou X, Liao Q, Chen G and Zhao Y: Predictive factors of lateral lymph node metastasis in papillary thyroid microcarcinoma. Pathol Oncol Res. 25:1245–1251. 2019. View Article : Google Scholar : PubMed/NCBI